Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 1,922 · FY2023 1,822 · FY2024 3,822 — 3-yr total 7,566
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides diagnostic and treatment services for gynaecology, infertility, and related medical specialties including ICSI and endocrinology.
Subsidiary of Inova (70.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 880 | 1,132 | 1,986 | 1,997 | 2,022 | 2,398 | 3,670 | 3,833 | +23.4% | |
| 1,142 | 949 | 644 | 460 | 412 | 357 | 748 | 675 | -7.2% | |
| TOTAL ASSETS | 2,022 | 2,081 | 2,630 | 2,457 | 2,434 | 2,755 | 4,418 | 4,508 | +12.1% |
| Total Current Liabilities | 134 | 333 | 854 | 1,114 | 924 | 479 | 472 | 430 | +18.1% |
| Total Non-Current Liabilities | 426 | 208 | 6 | 0 | 0 | 0 | 0 | 0 | -88.1% |
| TOTAL LIABILITIES | 560 | 541 | 860 | 1,114 | 924 | 479 | 472 | 430 | -3.7% |
| 1,462 | 1,540 | 1,770 | 1,343 | 1,510 | 2,276 | 3,946 | 4,078 | +15.8% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 426 | 208 | 6 | 0 | 0 | 0 | 0 | 0 | -88.1% |
| Cash & Equivalents | 234 | 235 | 485 | 663 | 786 | 766 | 1,465 | 1,334 | +28.2% |
| Net Debt | 192 | 27 | 479 | 663 | 786 | 766 | 1,465 | 1,334 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →